| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Less deemed dividend on series c convertible preferred stock | -385 | -818 | -789 | - |
| Net income (loss) attributable to pavmed inc. common stockholders | -6,328 | -13,308 | 17,695 | 64,316 |
| Net income (loss) per share attributable to pavmed inc. common stockholders basic | -0.29 | -0.74 | 1.28 | 6.43 |
| Net income (loss) per share attributable to pavmed inc. common stockholders diluted | -0.29 | -0.74 | 0.34 | 1.44 |
| Weighted average common shares outstanding, basic | 21,554,546 | 18,084,653 | 13,876,165 | 10,005,379 |
| Weighted average common shares outstanding, diluted | 21,554,546 | 18,084,653 | 52,496,401 | 44,475,638 |
PAVmed Inc. (PAVM)
PAVmed Inc. (PAVM)